Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome


Por: Lleo, A, Zetterberg, H, Pegueroles, J, Karikari, TK, Carmona-Iragui, M, Ashton, NJ, Montal, V, Barroeta, I, Lantero-Rodriguez, J, Videla, L, Altuna, M, Benejam, B, Fernandez, S, Valldeneu, S, Garzon, D, Bejanin, A, Iulita, MF, Camacho, V, Medrano-Martorell, S, Belbin, O, Clarimon, J, Lehmann, S, Alcolea, D, Blesa, R, Blennow, K, Fortea, J

Publicada: 14 jul 2021
Resumen:
Plasma tau phosphorylated at threonine 181 (p-tau181) predicts Alzheimer's disease (AD) pathology with high accuracy in the general population. In this study, we investigated plasma p-tau181 as a biomarker of AD in individuals with Down syndrome (DS). We included 366 adults with DS (240 asymptomatic, 43 prodromal AD, 83 AD dementia) and 44 euploid cognitively normal controls. We measured plasma p-tau181 with a Single molecule array (Simoa) assay. We examined the diagnostic performance of p-tau181 for the detection of AD and the relationship with other fluid and imaging biomarkers. Plasma p-tau181 concentration showed an area under the curve of 0.80 [95% CI 0.73-0.87] and 0.92 [95% CI 0.89-0.95] for the discrimination between asymptomatic individuals versus those in the prodromal and dementia groups, respectively. Plasma p-tau181 correlated with atrophy and hypometabolism in temporoparietal regions. Our findings indicate that plasma p-tau181 concentration can be useful to detect AD in DS. Plasma tau phosphorylated at threonine 181 (p-tau181) predicts Alzheimer's disease (AD) pathology. Here, the authors investigated whether plasma ptau181 could be a potential biomarker of AD in individuals with Down syndrome (DS) and find plasma p-tau181 can detect AD in DS adults.

Filiaciones:
Lleo, A:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

Zetterberg, H:
 Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden

 Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden

 UK Dementia Res Inst UCL, London, England

 UCL Inst Neurol, Dept Neurodegenerat Dis, London, England

Pegueroles, J:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

Karikari, TK:
 Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden

Carmona-Iragui, M:
 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

 Fundacio Catalana Sindrome Down, Barcelona Med Ctr, Barcelona, Spain

 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

Ashton, NJ:
 Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden

 Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden

 Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Old Age Psychiat, London, England

 South London & Maudsley NHS Fdn, NIHR Biomed Res Ctr, Mental Hlth & Biomed Res Unit Dementia, London, England

Montal, V:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

Barroeta, I:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

Lantero-Rodriguez, J:
 Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden

Videla, L:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

 Fundacio Catalana Sindrome Down, Barcelona Med Ctr, Barcelona, Spain

Altuna, M:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

Benejam, B:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

 Fundacio Catalana Sindrome Down, Barcelona Med Ctr, Barcelona, Spain

Fernandez, S:
 Fundacio Catalana Sindrome Down, Barcelona Med Ctr, Barcelona, Spain

Valldeneu, S:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

Garzon, D:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

Bejanin, A:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

Iulita, MF:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

Camacho, V:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

Medrano-Martorell, S:
 Univ Autonoma Barcelona UAB, Hosp del Mar, Barcelona, Spain

Belbin, O:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

Clarimon, J:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

Lehmann, S:
 Univ Montpellier, CHU Montpellier, Inst Neurosci Montpellier, INSERM, Montpellier, France

Alcolea, D:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

Blesa, R:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

Blennow, K:
 Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden

 Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden

Fortea, J:
 Univ Autonoma Barcelona, Biomed Res Inst St Pau, Hosp Santa Creu St Pau, Dept Neurol,Memory Unit, Barcelona, Spain

 Centro Invest Biomed Red Enfermedades Neurodegene, Madrid, Spain

 Fundacio Catalana Sindrome Down, Barcelona Med Ctr, Barcelona, Spain
ISSN: 20411723





Nature Communications
Editorial
NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 12 Número: 1
Páginas:
WOS Id: 000675628800009
ID de PubMed: 34262030
imagen Green Published, gold

MÉTRICAS